Alroy-Preis: Initial reports question vaccine strength against new variant
Alroy-Preis added that the South African strain is troubling because it might lead to higher rates of infection amongst the younger populations.
Head of Public Health Services Dr. Sharon Alroy-Preis receives the coronavirus vaccine, Rabin Medical Center-Beilinson Campus, December 20, 2020(photo credit: RABIN MEDICAL CENTER)BySARAH BEN-NUN